HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

8,9-dihydro-8,9-dihydroxybenzanthracene 10,11-oxide

RN given refers to cpd without isomeric designation; structure given in first source
Also Known As:
8,9,10,11-tetrahydrobenzanthracene-8,9-diol-10,11-epoxide; 8,9-DETBA; 8,9-DI-10,11-EP-THBA; 8,9-dihydro-8,9-dihydroxybenz(a)anthracene 10,11-oxide; 8,9-dihydro-8,9-dihydroxybenzanthracene 10,11-oxide, (1aR-(1aalpha,2alpha,3beta,11balpha))-isomer; 8,9-dihydro-8,9-dihydroxybenzanthracene 10,11-oxide, (1aS-(1aalpha,2beta,3alpha,11balpha))-isomer; 8,9-dihydro-8,9-dihydroxybenzanthracene 10,11-oxide, (1aalpha,2alpha,3beta,11balpha)-(+-)-isomer; 8,9-dihydro-8,9-dihydroxybenzanthracene 10,11-oxide, (1aalpha,2alpha,3beta,11balpha)-isomer; 8,9-dihydro-8,9-dihydroxybenzanthracene 10,11-oxide, (1aalpha,2beta,3alpha,11balpha)-(+-)-isomer; 8,9-dihydro-8,9-dihydroxybenzanthracene 10,11-oxide, (1aalpha,2beta,3alpha,11balpha)-isomer; 8,9-dihydroxy-10,11-epoxy-8,9,10,11--tetrahydrobenz(a)anthracene; 8,9-dihydroxy-10,11-epoxy-8,9,10,11-tetrahydrobenz(a)anthracene; anti-8,9-diol 10,11-oxide benz(a)anthracene; anti-BA-8,9-diol 10,11-oxide
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results